Defining and conceptualising the commercial determinants of health

AB Gilmore, A Fabbri, F Baum, A Bertscher, K Bondy… - The Lancet, 2023 - thelancet.com
Although commercial entities can contribute positively to health and society there is growing
evidence that the products and practices of some commercial actors—notably the largest …

[HTML][HTML] How does the tobacco industry attempt to influence marketing regulations? A systematic review

E Savell, AB Gilmore, G Fooks - PloS one, 2014 - journals.plos.org
Background The Framework Convention on Tobacco Control makes a number of
recommendations aimed at restricting the marketing of tobacco products. Tobacco industry …

Exposing and addressing tobacco industry conduct in low-income and middle-income countries

AB Gilmore, G Fooks, J Drope, SA Bialous, RR Jackson - The Lancet, 2015 - thelancet.com
The tobacco industry's future depends on increasing tobacco use in low-income and middle-
income countries (LMICs), which face a growing burden of tobacco-related disease, yet …

[图书][B] Beyond evidence based policy in public health: The interplay of ideas

K Smith - 2013 - books.google.com
This book explores the complex relationship between public health research and policy,
employing tobacco control and health inequalities in the UK as contrasting case studies. It …

[HTML][HTML] The policy dystopia model: an interpretive analysis of tobacco industry political activity

S Ulucanlar, GJ Fooks, AB Gilmore - PLoS medicine, 2016 - journals.plos.org
Background Tobacco industry interference has been identified as the greatest obstacle to
the implementation of evidence-based measures to reduce tobacco use. Understanding and …

[HTML][HTML] The limits of corporate social responsibility: techniques of neutralization, stakeholder management and political CSR

G Fooks, A Gilmore, J Collin, C Holden, K Lee - Journal of business ethics, 2013 - Springer
Since scholarly interest in corporate social responsibility (CSR) has primarily focused on the
synergies between social and economic performance, our understanding of how (and the …

[HTML][HTML] The science for profit model—how and why corporations influence science and the use of science in policy and practice

T Legg, J Hatchard, AB Gilmore - Plos one, 2021 - journals.plos.org
Science has been at the centre of attempts by major industries, including tobacco, chemical,
and pharmaceutical, to delay progress in tackling threats to human and planetary health by …

[HTML][HTML] Corporate practices and health: a framework and mechanisms

J Madureira Lima, S Galea - Globalization and Health, 2018 - Springer
Abstract Background The Global Burden of Disease estimates that approximately a third of
deaths worldwide are attributable to behavioural risk factors that, at their core, have the …

The case for developing a cohesive systems approach to research across unhealthy commodity industries

C Knai, M Petticrew, S Capewell, R Cassidy… - BMJ Global …, 2021 - gh.bmj.com
Objectives Most non-communicable diseases are preventable and largely driven by the
consumption of harmful products, such as tobacco, alcohol, gambling and ultra-processed …

[HTML][HTML] Science, the endless frontier of regulatory capture

A Saltelli, DJ Dankel, M Di Fiore, N Holland, M Pigeon - Futures, 2022 - Elsevier
In this paper we explore five recent cases of regulatory capture in Europe and zoom in on a
form of corporate penetration which is based on a strategic use of the image and legitimacy …